These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17848805)

  • 1. Year-to-year variation in release of Bet v 1 allergen from birch pollen: evidence for geographical differences between West and South Germany.
    Buters JT; Kasche A; Weichenmeier I; Schober W; Klaus S; Traidl-Hoffmann C; Menzel A; Huss-Marp J; Kramer U; Behrendt H
    Int Arch Allergy Immunol; 2008; 145(2):122-30. PubMed ID: 17848805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular composition and biological activity of commercial birch pollen allergen extracts.
    Focke M; Marth K; Valenta R
    Eur J Clin Invest; 2009 May; 39(5):429-36. PubMed ID: 19302561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP system in patients with pollen-related allergy to birch and apple.
    Rossi RE; Monasterolo G; Operti D; Corsi M
    Allergy; 1996 Dec; 51(12):940-5. PubMed ID: 9020425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
    Larenas-Linnemann D
    Curr Opin Investig Drugs; 2010 May; 11(5):586-96. PubMed ID: 20419605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification in mass units of Bet v 1, the main allergen of Betula verrucosa pollen, by a monoclonal antibody based-ELISA.
    Ramírez J; Carpizo JA; Ipsen H; Carreira J; Lombardero M
    Clin Exp Allergy; 1997 Aug; 27(8):926-31. PubMed ID: 9291291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant birch allergens (Bet v 1 and Bet v 2) and the oral allergy syndrome in patients allergic to birch pollen.
    De Amici M; Mosca M; Vignini M; Quaglini S; Moratti R
    Ann Allergy Asthma Immunol; 2003 Nov; 91(5):490-2. PubMed ID: 14692434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G4-antibodies to rBet v 1 and risk of sensitization and atopic disease in the child.
    Kihlström A; Hedlin G; Pershagen G; Troye-Blomberg M; Härfast B; Lilja G
    Clin Exp Allergy; 2005 Dec; 35(12):1542-9. PubMed ID: 16393319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001.
    Smole U; Balazs N; Hoffmann-Sommergruber K; Radauer C; Hafner C; Wallner M; Ferreira F; Grössinger R; de Jong EC; Wagner S; Breiteneder H
    Immunobiology; 2010 Nov; 215(11):903-9. PubMed ID: 20005001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The allergen Bet v 1 in fractions of ambient air deviates from birch pollen counts.
    Buters JT; Weichenmeier I; Ochs S; Pusch G; Kreyling W; Boere AJ; Schober W; Behrendt H
    Allergy; 2010 Jul; 65(7):850-8. PubMed ID: 20132158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soybean allergy in patients allergic to birch pollen: clinical investigation and molecular characterization of allergens.
    Mittag D; Vieths S; Vogel L; Becker WM; Rihs HP; Helbling A; Wüthrich B; Ballmer-Weber BK
    J Allergy Clin Immunol; 2004 Jan; 113(1):148-54. PubMed ID: 14713921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
    Ebner C; Schenk S; Najafian N; Siemann U; Steiner R; Fischer GW; Hoffmann K; Szépfalusi Z; Scheiner O; Kraft D
    J Immunol; 1995 Feb; 154(4):1932-40. PubMed ID: 7530747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
    Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
    Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen bet v 1 and to recombinant bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients.
    Nopp A; Halldén G; Lundahl J; Johansson E; Vrtala S; Valenta R; Grönneberg R; Van Hage-Hamsten M
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):101-9. PubMed ID: 10887312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of the major oak pollen allergen Que a 1 for component-resolved diagnostics using ImmunoCAP.
    Movérare R; Everberg H; Carlsson R; Holtz A; Thunberg R; Olsson P; Brostedt P; Hogbom E
    Int Arch Allergy Immunol; 2008; 146(3):203-11. PubMed ID: 18268388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of the major group 1 allergen from Bahia grass pollen, Pas n 1.
    Drew AC; Davies JM; Dang TD; Rolland JM; O'Hehir RE
    Int Arch Allergy Immunol; 2011; 154(4):295-8. PubMed ID: 20962534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly.
    Campana R; Vrtala S; Maderegger B; Jertschin P; Stegfellner G; Swoboda I; Focke-Tejkl M; Blatt K; Gieras A; Zafred D; Neubauer A; Valent P; Keller W; Spitzauer S; Valenta R
    J Allergy Clin Immunol; 2010 Nov; 126(5):1024-31, 1031.e1-8. PubMed ID: 20638112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serologic and skin test diagnosis of birch pollen allergy with recombinant Bet v 1, the chief allergen of birch].
    Menz G; Dolecek C; Schönheit-Kenn U; Ferreira F; Moser M; Schneider T; Suter M; Boltz-Nitulescu G; Ebner C; Kraft D; Valenta R
    Pneumologie; 1996 Sep; 50(9):632-40. PubMed ID: 9011868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Bet v 1 and Bet v 2 specific IgE and food allergy in children with grass pollen respiratory allergy.
    Ricci G; Righetti F; Menna G; Bellini F; Miniaci A; Masi M
    Mol Immunol; 2005 Jun; 42(10):1251-7. PubMed ID: 15829314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.